{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T07:29:03Z","timestamp":1790753343263,"version":"4.1.0"},"reference-count":71,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seminarsinnephrology.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Nephrology"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.semnephrol.2022.04.002","type":"journal-article","created":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T22:15:05Z","timestamp":1655417705000},"page":"114-121","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["X-Linked Kidney Disorders in Women"],"prefix":"10.1016","volume":"42","author":[{"given":"Catherine","family":"Quinlan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle N.","family":"Rheault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semnephrol.2022.04.002_bib0001","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/newbio230154a0","article-title":"Inheritance of glucose-6-phosphate dehydrogenase variation in kangaroos","volume":"230","author":"Richardson","year":"1971","journal-title":"Nat New Biol."},{"key":"10.1016\/j.semnephrol.2022.04.002_bib0002","doi-asserted-by":"crossref","first-page":"204","DOI":"10.4161\/epi.26939","article-title":"Understanding the X chromosome inactivation cycle in mice: a comprehensive view provided by nuclear transfer","volume":"9","author":"Oikawa","year":"2014","journal-title":"Epigenetics."},{"key":"10.1016\/j.semnephrol.2022.04.002_bib0003","first-page":"147","article-title":"X chromosome inactivation in human development","author":"Patrat","year":"2020","journal-title":"Development."},{"key":"10.1016\/j.semnephrol.2022.04.002_bib0004","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.cell.2016.08.009","article-title":"Single-cell RNA-seq reveals lineage and X chromosome dynamics in human preimplantation embryos","volume":"167","author":"Petropoulos","year":"2016","journal-title":"Cell."},{"key":"10.1016\/j.semnephrol.2022.04.002_bib0005","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1681\/ASN.2008020198","article-title":"X inactivation, female mosaicism, and sex differences in renal diseases","volume":"19","author":"Migeon","year":"2008","journal-title":"J Am Soc Nephrol."},{"key":"10.1016\/j.semnephrol.2022.04.002_bib0006","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/BF03403532","article-title":"X chromosome inactivation patterns correlate with fetal-placental anatomy in monozygotic twin pairs: implications for immune relatedness and concordance for autoimmunity","volume":"1","author":"Trejo","year":"1994","journal-title":"Mol Med."},{"key":"10.1016\/j.semnephrol.2022.04.002_bib0007","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1750-1172-5-14","article-title":"Expression of the disease on female carriers of X-linked lysosomal disorders: a brief review","volume":"5","author":"Pinto","year":"2010","journal-title":"Orphanet J Rare Dis."},{"key":"10.1016\/j.semnephrol.2022.04.002_bib0008","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/nature24265","article-title":"Landscape of X chromosome inactivation across human tissues","volume":"550","author":"Tukiainen","year":"2017","journal-title":"Nature."},{"key":"10.1016\/j.semnephrol.2022.04.002_bib0009","doi-asserted-by":"crossref","DOI":"10.1093\/hmg\/ddy148","article-title":"The eXceptional nature of the X chromosome","volume":"27","author":"Balaton","year":"2018","journal-title":"Hum Mol Genet."},{"key":"10.1016\/j.semnephrol.2022.04.002_bib0010","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.gde.2006.04.012","article-title":"X-inactivation and human disease: X-linked dominant male-lethal disorders","volume":"16","author":"Franco","year":"2006","journal-title":"Curr Opin Genet Dev."},{"key":"10.1016\/j.semnephrol.2022.04.002_bib0011","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1097\/01.ASN.0000141462.00630.76","article-title":"The molecular basis of Goodpasture and Alport syndromes: beacons for the discovery of the collagen IV family","volume":"15","author":"Hudson","year":"2004","journal-title":"J Am Soc Nephrol."},{"key":"10.1016\/j.semnephrol.2022.04.002_bib0012","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.2215\/CJN.19171220","article-title":"Genetic basis of type IV collagen disorders of the kidney","volume":"16","author":"Quinlan","year":"2021","journal-title":"Clin J Am Soc Nephrol."},{"key":"10.1016\/j.semnephrol.2022.04.002_bib0013","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.2215\/CJN.00580116","article-title":"Alport syndrome in women and girls","volume":"11","author":"Savige","year":"2016","journal-title":"Clin J Am Soc Nephrol."},{"key":"10.1016\/j.semnephrol.2022.04.002_bib0014","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.kint.2017.12.018","article-title":"Alport syndrome: a unified classification of genetic disorders of collagen IV alpha345: a position paper of the Alport Syndrome Classification Working Group","volume":"93","author":"Kashtan","year":"2018","journal-title":"Kidney Int."},{"key":"10.1016\/j.semnephrol.2022.04.002_bib0015","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1681\/ASN.V114649","article-title":"X-linked Alport syndrome: natural history in 195 families and genotype- phenotype correlations in males","volume":"11","author":"Jais","year":"2000","journal-title":"J Am Soc Nephrol."},{"key":"10.1016\/j.semnephrol.2022.04.002_bib0016","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/j.kint.2020.06.038","article-title":"Genotype-phenotype correlation and the influence of the genotype on response to angiotensin-targeting drugs in Japanese patients with male X-linked Alport syndrome","volume":"98","author":"Yamamura","year":"2020","journal-title":"Kidney Int."},{"key":"10.1016\/j.semnephrol.2022.04.002_bib0017","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1136\/bmj.1.3454.504","article-title":"Hereditary familial congenital haemorrhagic nephritis","volume":"1","author":"Alport","year":"1927","journal-title":"Br Med J."},{"key":"10.1016\/j.semnephrol.2022.04.002_bib0018","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1146\/annurev.me.15.020164.000555","article-title":"Familial aspects of diffuse renal diseases","volume":"15","author":"Perkoff","year":"1964","journal-title":"Annu Rev Med."},{"key":"10.1016\/j.semnephrol.2022.04.002_bib0019","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1097\/01.ASN.0000090034.71205.74","article-title":"X-linked Alport syndrome: natural history and genotype-phenotype correlations in girls and women belonging to 195 families: a \u201cEuropean Community Alport Syndrome Concerted Action\u201d study","volume":"14","author":"Jais","year":"2003","journal-title":"J Am Soc Nephrol."},{"key":"10.1016\/j.semnephrol.2022.04.002_bib0020","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.ekir.2017.04.011","article-title":"Natural history and genotype-phenotype correlation in female X-linked Alport syndrome","volume":"2","author":"Yamamura","year":"2017","journal-title":"Kidney Int Rep."},{"key":"10.1016\/j.semnephrol.2022.04.002_bib0021","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/ki.2011.452","article-title":"Incidence of renal failure and nephroprotection by RAAS inhibition in heterozygous carriers of X-chromosomal and autosomal recessive Alport mutations","volume":"81","author":"Temme","year":"2012","journal-title":"Kidney Int."},{"key":"10.1016\/j.semnephrol.2022.04.002_bib0022","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1681\/ASN.2020060777","article-title":"Uncovering modifier genes of X-linked Alport syndrome using a novel multiparent mouse model","volume":"32","author":"Takemon","year":"2021","journal-title":"J Am Soc Nephrol."},{"key":"10.1016\/j.semnephrol.2022.04.002_bib0023","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1172\/JCI117862","article-title":"Severe Alport phenotype in a woman with two missense mutations in the same COL4A5 gene and preponderant inactivation of the X chromosome carrying the normal allele","volume":"95","author":"Guo","year":"1995","journal-title":"J Clin Invest."},{"key":"10.1016\/j.semnephrol.2022.04.002_bib0024","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1007\/s00467-010-1514-1","article-title":"Severe Alport syndrome in a young woman caused by a t(X;1)(q22.3;p36.32) balanced translocation","volume":"25","author":"Iijima","year":"2010","journal-title":"Pediatr Nephrol."},{"key":"10.1016\/j.semnephrol.2022.04.002_bib0025","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1093\/ndt\/gfp551","article-title":"X-inactivation modifies disease severity in female carriers of murine X-linked Alport syndrome","volume":"25","author":"Rheault","year":"2010","journal-title":"Nephrol Dial Transplant."},{"key":"10.1016\/j.semnephrol.2022.04.002_bib0026","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1681\/ASN.V981433","article-title":"Comparison of alpha5(IV) collagen chain expression in skin with disease severity in women with X-linked Alport syndrome","volume":"9","author":"Nakanishi","year":"1998","journal-title":"J Am Soc Nephrol."},{"key":"10.1016\/j.semnephrol.2022.04.002_bib0027","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1046\/j.1523-1755.2003.00251.x","article-title":"Epidermal basement membrane alpha 5(IV) expression in females with Alport syndrome and severity of renal disease","volume":"64","author":"Massella","year":"2003","journal-title":"Kidney Int."},{"key":"10.1016\/j.semnephrol.2022.04.002_bib0028","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1136\/jmg.2007.055244","article-title":"Comparison of X-chromosome inactivation patterns in multiple tissues from human females","volume":"45","author":"Bittel","year":"2008","journal-title":"J Med Genet."},{"key":"10.1016\/j.semnephrol.2022.04.002_bib0029","first-page":"638","article-title":"Correlation between mRNA expression level of the mutant COL4A5 gene and phenotypes of XLAS females","volume":"232","author":"Wang","year":"2007","journal-title":"Exp Biol Med (Maywood)."},{"key":"10.1016\/j.semnephrol.2022.04.002_bib0030","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1136\/jmg.29.9.663","article-title":"X inactivation patterns in females with Alport's syndrome: a means of selecting against a deleterious gene?","volume":"29","author":"Vetrie","year":"1992","journal-title":"J Med Genet."},{"key":"10.1016\/j.semnephrol.2022.04.002_bib0031","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s00467-020-04819-6","article-title":"Clinical practice recommendations for the diagnosis and management of Alport syndrome in children, adolescents, and young adults-an update for 2020","volume":"36","author":"Kashtan","year":"2021","journal-title":"Pediatr Nephrol."},{"key":"10.1016\/j.semnephrol.2022.04.002_bib0032","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/ki.2011.407","article-title":"Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy","volume":"81","author":"Gross","year":"2012","journal-title":"Kidney Int."},{"key":"10.1016\/j.semnephrol.2022.04.002_bib0033","doi-asserted-by":"crossref","unstructured":"Di H, Zhang J, Gao E, et\u00a0al. Dissecting the genotype-phenotype correlation of COL4A5 gene mutation and its response to renin-angiotensin-aldosterone system blockers in Chinese male patients with Alport syndrome. Nephrol Dial Transplant. Published online January 10, 2022. doi:10.1093\/ndt\/gfac002.","DOI":"10.1093\/ndt\/gfac002"},{"key":"10.1016\/j.semnephrol.2022.04.002_bib0034","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00467-016-3452-z","article-title":"Prospective study on the potential of RAAS blockade to halt renal disease in Alport syndrome patients with heterozygous mutations","volume":"32","author":"Stock","year":"2017","journal-title":"Pediatr Nephrol."},{"key":"10.1016\/j.semnephrol.2022.04.002_bib0035","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1681\/ASN.2014050459","article-title":"Risk of adverse pregnancy outcomes in women with CKD","volume":"26","author":"Piccoli","year":"2015","journal-title":"J Am Soc Nephrol."},{"key":"10.1016\/j.semnephrol.2022.04.002_bib0036","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.kint.2015.12.050","article-title":"Pregnancy across the spectrum of chronic kidney disease","volume":"89","author":"Hladunewich","year":"2016","journal-title":"Kidney Int."},{"key":"10.1016\/j.semnephrol.2022.04.002_bib0037","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.2215\/CJN.00130117","article-title":"Pregnancy and glomerular disease: a systematic review of the literature with management guidelines","volume":"12","author":"Blom","year":"2017","journal-title":"Clin J Am Soc Nephrol."},{"key":"10.1016\/j.semnephrol.2022.04.002_bib0038","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1007\/s00404-018-4720-x","article-title":"Alport syndrome and pregnancy: a case series and literature review","volume":"297","author":"Brunini","year":"2018","journal-title":"Arch Gynecol Obstet."},{"key":"10.1016\/j.semnephrol.2022.04.002_bib0039","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1093\/ndt\/gfn779","article-title":"Women with Alport syndrome: risks and rewards of kidney donation","volume":"24","author":"Kashtan","year":"2009","journal-title":"Nephrol Dial Transplant."},{"key":"10.1016\/j.semnephrol.2022.04.002_bib0040","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1093\/ndt\/gfn635","article-title":"Living donor kidney transplantation from relatives with mild urinary abnormalities in Alport syndrome: long-term risk, benefit and outcome","volume":"24","author":"Gross","year":"2009","journal-title":"Nephrol Dial Transplant."},{"key":"10.1016\/j.semnephrol.2022.04.002_bib0041","first-page":"337","article-title":"2021 TSOC expert consensus on the clinical features, diagnosis, and clinical management of cardiac manifestations of Fabry disease","volume":"37","author":"Hung","year":"2021","journal-title":"Acta Cardiol Sin."},{"key":"10.1016\/j.semnephrol.2022.04.002_bib0042","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/S0140-6736(08)61589-5","article-title":"Fabry's disease","volume":"372","author":"Zarate","year":"2008","journal-title":"Lancet."},{"key":"10.1016\/j.semnephrol.2022.04.002_bib0043","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/ndt\/gfab038","article-title":"Precision medicine in Fabry disease","volume":"36","author":"Lenders","year":"2021","journal-title":"Nephrol Dial Transplant."},{"key":"10.1016\/j.semnephrol.2022.04.002_bib0044","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1681\/ASN.2016090964","article-title":"Characterization of classical and nonclassical Fabry disease: a multicenter study","volume":"28","author":"Arends","year":"2017","journal-title":"J Am Soc Nephrol."},{"key":"10.1016\/j.semnephrol.2022.04.002_bib0045","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/GIM.0b013e31802d8321","article-title":"Heterozygous Fabry women are not just carriers, but have a significant burden of disease and impaired quality of life","volume":"9","author":"Wang","year":"2007","journal-title":"Genet Med."},{"key":"10.1016\/j.semnephrol.2022.04.002_bib0046","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1136\/jmg.2005.036327","article-title":"Natural history of Fabry disease in females in the Fabry Outcome Survey","volume":"43","author":"Deegan","year":"2006","journal-title":"J Med Genet."},{"key":"10.1016\/j.semnephrol.2022.04.002_bib0047","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1097\/GIM.0b013e3181bb05bb","article-title":"Life expectancy and cause of death in males and females with Fabry disease: findings from the Fabry Registry","volume":"11","author":"Waldek","year":"2009","journal-title":"Genet Med."},{"key":"10.1016\/j.semnephrol.2022.04.002_bib0048","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1093\/ndt\/gfm848","article-title":"Nephropathy in males and females with Fabry disease: cross-sectional description of patients before treatment with enzyme replacement therapy","volume":"23","author":"Ortiz","year":"2008","journal-title":"Nephrol Dial Transplant."},{"key":"10.1016\/j.semnephrol.2022.04.002_bib0049","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/ndt\/gfp554","article-title":"End-stage renal disease in patients with Fabry disease: natural history data from the Fabry Registry","volume":"25","author":"Ortiz","year":"2010","journal-title":"Nephrol Dial Transplant."},{"key":"10.1016\/j.semnephrol.2022.04.002_bib0050","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ymgme.2007.09.013","article-title":"Females with Fabry disease frequently have major organ involvement: lessons from the Fabry Registry","volume":"93","author":"Wilcox","year":"2008","journal-title":"Mol Genet Metab."},{"key":"10.1016\/j.semnephrol.2022.04.002_bib0051","series-title":"Fabry Disease: Perspectives From 5 Years of FOS","article-title":"Nervous system manifestations of Fabry disease: data from FOS - the Fabry Outcome Survey","author":"Ginsberg","year":"2006"},{"key":"10.1016\/j.semnephrol.2022.04.002_bib0052","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ekir.2019.11.013","article-title":"Current and investigational therapeutics for Fabry disease","volume":"5","author":"Felis","year":"2020","journal-title":"Kidney Int Rep."},{"key":"10.1016\/j.semnephrol.2022.04.002_bib0053","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.beem.2016.02.010","article-title":"Genetic forms of nephrogenic diabetes insipidus (NDI): Vasopressin receptor defect (X-linked) and aquaporin defect (autosomal recessive and dominant)","volume":"30","author":"Bichet","year":"2016","journal-title":"Best Pract Res Clin Endocrinol Metab."},{"key":"10.1016\/j.semnephrol.2022.04.002_bib0054","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/BF03346263","article-title":"A novel deletion mutation in the arginine vasopressin receptor 2 gene and skewed X chromosome inactivation in a female patient with congenital nephrogenic diabetes insipidus","volume":"27","author":"Kinoshita","year":"2004","journal-title":"J Endocrinol Invest."},{"key":"10.1016\/j.semnephrol.2022.04.002_bib0055","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/s10157-012-0726-z","article-title":"Hereditary nephrogenic diabetes insipidus in Japanese patients: analysis of 78 families and report of 22 new mutations in AVPR2 and AQP2","volume":"17","author":"Sasaki","year":"2013","journal-title":"Clin Exp Nephrol."},{"key":"10.1016\/j.semnephrol.2022.04.002_bib0056","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/BF00214189","article-title":"Clinical phenotype of nephrogenic diabetes insipidus in females heterozygous for a vasopressin type 2 receptor mutation","volume":"96","author":"van Lieburg","year":"1995","journal-title":"Hum Genet."},{"key":"10.1016\/j.semnephrol.2022.04.002_bib0057","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/humu.24296","article-title":"Novel PHEX gene locus-specific database: comprehensive characterization of vast number of variants associated with X-linked hypophosphatemia (XLH)","volume":"43","author":"Sarafrazi","year":"2022","journal-title":"Hum Mutat."},{"key":"10.1016\/j.semnephrol.2022.04.002_bib0058","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41439-020-0095-1","article-title":"Phenotypes of a family with XLH with a novel PHEX mutation","volume":"7","author":"Yamamoto","year":"2020","journal-title":"Hum Genome Var."},{"key":"10.1016\/j.semnephrol.2022.04.002_bib0059","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00467-011-2046-z","article-title":"Growth in PHEX-associated X-linked hypophosphatemic rickets: the importance of early treatment","volume":"27","author":"Quinlan","year":"2012","journal-title":"Pediatr Nephrol."},{"key":"10.1016\/j.semnephrol.2022.04.002_bib0060","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41581-019-0152-5","article-title":"Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia","volume":"15","author":"Haffner","year":"2019","journal-title":"Nat Rev Nephrol."},{"key":"10.1016\/j.semnephrol.2022.04.002_bib0061","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/1471-2350-12-116","article-title":"Genetic diagnosis of X-linked dominant hypophosphatemic rickets in a cohort study: tubular reabsorption of phosphate and 1,25(OH)2D serum levels are associated with PHEX mutation type","volume":"12","author":"Morey","year":"2011","journal-title":"BMC Med Genet."},{"key":"10.1016\/j.semnephrol.2022.04.002_bib0062","doi-asserted-by":"crossref","first-page":"3889","DOI":"10.1210\/jcem.86.8.7761","article-title":"Mutational analysis and genotype-phenotype correlation of the PHEX gene in X-linked hypophosphatemic rickets","volume":"86","author":"Holm","year":"2001","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.semnephrol.2022.04.002_bib0063","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00439-020-02219-2","article-title":"Genetics and phenotypic heterogeneity of Dent disease: the dark side of the moon","volume":"140","author":"Gianesello","year":"2021","journal-title":"Hum Genet."},{"key":"10.1016\/j.semnephrol.2022.04.002_bib0064","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2016.04.007","article-title":"Dent disease in Chinese children and findings from heterozygous mothers: phenotypic heterogeneity, fetal growth, and 10 novel mutations","volume":"174","author":"Li","year":"2016","journal-title":"J Pediatr."},{"key":"10.1016\/j.semnephrol.2022.04.002_bib0065","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s12882-020-01827-4","article-title":"Case report: a Chinese girl with dent disease 1 and turner syndrome due to a hemizygous CLCN5 gene mutation and Isochromosome (Xq)","volume":"21","author":"Ye","year":"2020","journal-title":"BMC Nephrol."},{"key":"10.1016\/j.semnephrol.2022.04.002_bib0066","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1750-1172-1-16","volume":"1","author":"syndrome","year":"2006","journal-title":"Orphanet J Rare Dis."},{"key":"10.1016\/j.semnephrol.2022.04.002_bib0067","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nrneph.2017.83","article-title":"The 5-phosphatase OCRL in Lowe syndrome and Dent disease 2","volume":"13","author":"De Matteis","year":"2017","journal-title":"Nat Rev Nephrol."},{"key":"10.1016\/j.semnephrol.2022.04.002_bib0068","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1515\/hsz-2015-0180","article-title":"The role of the Lowe syndrome protein OCRL in the endocytic pathway","volume":"396","author":"Sharma","year":"2015","journal-title":"Biol Chem."},{"key":"10.1016\/j.semnephrol.2022.04.002_bib0069","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1093\/hmg\/ddy449","article-title":"OCRL deficiency impairs endolysosomal function in a humanized mouse model for Lowe syndrome and Dent disease","volume":"28","author":"Festa","year":"2019","journal-title":"Hum Mol Genet."},{"key":"10.1016\/j.semnephrol.2022.04.002_bib0070","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.pedneo.2018.03.006","article-title":"Application of chromosome microarray analysis in patients with unexplained developmental delay\/intellectual disability in South China","volume":"60","author":"Wang","year":"2019","journal-title":"Pediatr Neonatol."},{"key":"10.1016\/j.semnephrol.2022.04.002_bib0071","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s13730-019-00434-z","article-title":"Complete oculocerebrorenal phenotype of Lowe syndrome in a female patient with half reduction of inositol polyphosphate 5-phosphatase","volume":"9","author":"Yamamoto","year":"2020","journal-title":"CEN Case Rep."}],"container-title":["Seminars in Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929522000109?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929522000109?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T23:39:43Z","timestamp":1759448383000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0270929522000109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":71,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S0270929522000109"],"URL":"https:\/\/doi.org\/10.1016\/j.semnephrol.2022.04.002","relation":{},"ISSN":["0270-9295"],"issn-type":[{"value":"0270-9295","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"X-Linked Kidney Disorders in Women","name":"articletitle","label":"Article Title"},{"value":"Seminars in Nephrology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semnephrol.2022.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}